Interpace Biosciences Inc (IDXG)
1.54
+0.12
(+8.26%)
USD |
OTCM |
Apr 26, 11:24
Interpace Biosciences Market Cap: 6.740M for April 26, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 25, 2024 | 6.225M |
| April 24, 2024 | 6.792M |
| April 23, 2024 | 6.422M |
| April 22, 2024 | 6.346M |
| April 19, 2024 | 6.346M |
| April 18, 2024 | 6.433M |
| April 17, 2024 | 6.433M |
| April 16, 2024 | 6.433M |
| April 15, 2024 | 6.433M |
| April 12, 2024 | 6.061M |
| April 11, 2024 | 5.908M |
| April 10, 2024 | 6.477M |
| April 09, 2024 | 6.521M |
| April 08, 2024 | 6.346M |
| April 05, 2024 | 6.346M |
| April 04, 2024 | 6.652M |
| April 03, 2024 | 6.565M |
| April 02, 2024 | 6.565M |
| April 01, 2024 | 6.018M |
| March 28, 2024 | 6.565M |
| March 27, 2024 | 6.805M |
| March 26, 2024 | 7.002M |
| March 25, 2024 | 7.090M |
| March 22, 2024 | 7.090M |
| March 21, 2024 | 7.002M |
| Date | Value |
|---|---|
| March 20, 2024 | 7.177M |
| March 19, 2024 | 6.565M |
| March 18, 2024 | 6.565M |
| March 15, 2024 | 7.090M |
| March 14, 2024 | 7.180M |
| March 13, 2024 | 7.354M |
| March 12, 2024 | 7.389M |
| March 11, 2024 | 7.615M |
| March 08, 2024 | 7.093M |
| March 07, 2024 | 7.223M |
| March 06, 2024 | 5.222M |
| March 05, 2024 | 4.547M |
| March 04, 2024 | 4.547M |
| March 01, 2024 | 4.547M |
| February 29, 2024 | 4.569M |
| February 28, 2024 | 4.786M |
| February 27, 2024 | 4.569M |
| February 26, 2024 | 4.678M |
| February 23, 2024 | 4.726M |
| February 22, 2024 | 4.656M |
| February 21, 2024 | 4.569M |
| February 20, 2024 | 4.351M |
| February 16, 2024 | 4.569M |
| February 15, 2024 | 4.569M |
| February 14, 2024 | 4.204M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
2.816M
Minimum
Dec 27 2022
43.08M
Maximum
Jul 02 2021
18.36M
Average
17.19M
Median
Market Cap Benchmarks
| Fonar Corp | 107.81M |
| XWELL Inc | 7.739M |
| ProPhase Labs Inc | 87.34M |
| Applied DNA Sciences Inc | 3.944M |
| Veracyte Inc | 1.471B |
Market Cap Related Metrics
| PS Ratio | 0.1687 |
| Price | 1.54 |
| Earnings Yield | -3.25% |
| Operating PE Ratio | 2.242 |
| Normalized PE Ratio | 26.62 |